Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (γ-glutamate) metabolites-Reference-Cited by-同舟云学术

Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (γ-glutamate) metabolites

Published:1996-10 Issue:8 Volume:52 Page:1295-1303
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

McGuire John J.,Hart Barry P.,Haile William H.,Magee Kathryn J.,Rhee Myung,Bolanowska Wanda E.,Russell Cynthia,Galivan John,Paul Brajeswar,Coward James K.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference30 articles.

1. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism;Shane;Vitam Horm,1989

2. Pteroylpolyglutamates: Biosynthesis, degradation, and function;McGuire,1984

3. Isolation and biochemical characterization of folate deficient mutants of Chinese hamster cells;McBurney;Cell,1974

4. Rescue techniques in cancer chemotherapy: Use of leucovorin and other rescue agents after methotrexate treatment;Bertino,1977

5. The expanding role of folates and fluoropyrimidines in cancer chemotherapy;Rustum,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism‐Based Inhibitors of Folylpoly‐γ‐Glutamate Synthetase and γ‐Glutamyl Hydrolase: Control of Folylpoly‐γ‐Glutamate Homeostasis as a Drug Target;Folic Acid and Folates;2008

2. Drug Evolution: p-Aminobenzoic Acid as a Building Block;Current Medicinal Chemistry;2002-11-01

3. Electrophilic Fluorination of Pyroglutamic Acid Derivatives: Application of Substrate-Dependent Reactivity and Diastereoselectivity to the Synthesis of Optically Active 4-Fluoroglutamic Acids;The Journal of Organic Chemistry;2001-11-27

4. Synthesis of l-4,4-Difluoroglutamic Acid via Nucleophilic Addition to a Chiral Aldehyde;The Journal of Organic Chemistry;2001-08-25

5. The effect of side-chain, para-aminobenzoyl region, and B-ring modifications on dihydrofolate reductase binding, influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatable antifolate Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine;Pharmacology & Therapeutics;2000-03